logo
Breadcrumbs Image

Respiratory Drug Industry

Respiratory Drug Industry

2021-2027 Global and Regional Respiratory Drug Industry Status and Prospects Professional Market Research Report Standard Version


Date: Aug-2021 | Id: MACRC-72126 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Respiratory Drug market was valued at 3945.79 Million USD in 2020 and will grow with a CAGR of 5.53% from 2020 to 2027, based on Mnemonics Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%. Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.  North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period. Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.  
By Market Verdors:
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco

By Types:
Inhalable & Nasal Spray
Oral

By Applications:
Hospital
Drugs Store

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Respiratory Drug Market Size Analysis from 2022 to 2027
1.5.1 Global Respiratory Drug Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Respiratory Drug Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Respiratory Drug Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Respiratory Drug Industry Impact
Chapter 2 Global Respiratory Drug Competition by Types, Applications, and Top Regions and Countries
2.1 Global Respiratory Drug (Volume and Value) by Type
2.1.1 Global Respiratory Drug Consumption and Market Share by Type (2016-2021)
2.1.2 Global Respiratory Drug Revenue and Market Share by Type (2016-2021)
2.2 Global Respiratory Drug (Volume and Value) by Application
2.2.1 Global Respiratory Drug Consumption and Market Share by Application (2016-2021)
2.2.2 Global Respiratory Drug Revenue and Market Share by Application (2016-2021)
2.3 Global Respiratory Drug (Volume and Value) by Regions
2.3.1 Global Respiratory Drug Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Respiratory Drug Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Respiratory Drug Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Respiratory Drug Consumption by Regions (2016-2021)
4.2 North America Respiratory Drug Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Respiratory Drug Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Respiratory Drug Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Respiratory Drug Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Respiratory Drug Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Respiratory Drug Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Respiratory Drug Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Respiratory Drug Sales, Consumption, Export, Import (2016-2021)
4.10 South America Respiratory Drug Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Respiratory Drug Market Analysis
5.1 North America Respiratory Drug Consumption and Value Analysis
5.1.1 North America Respiratory Drug Market Under COVID-19
5.2 North America Respiratory Drug Consumption Volume by Types
5.3 North America Respiratory Drug Consumption Structure by Application
5.4 North America Respiratory Drug Consumption by Top Countries
5.4.1 United States Respiratory Drug Consumption Volume from 2016 to 2021
5.4.2 Canada Respiratory Drug Consumption Volume from 2016 to 2021
5.4.3 Mexico Respiratory Drug Consumption Volume from 2016 to 2021
Chapter 6 East Asia Respiratory Drug Market Analysis
6.1 East Asia Respiratory Drug Consumption and Value Analysis
6.1.1 East Asia Respiratory Drug Market Under COVID-19
6.2 East Asia Respiratory Drug Consumption Volume by Types
6.3 East Asia Respiratory Drug Consumption Structure by Application
6.4 East Asia Respiratory Drug Consumption by Top Countries
6.4.1 China Respiratory Drug Consumption Volume from 2016 to 2021
6.4.2 Japan Respiratory Drug Consumption Volume from 2016 to 2021
6.4.3 South Korea Respiratory Drug Consumption Volume from 2016 to 2021
Chapter 7 Europe Respiratory Drug Market Analysis
7.1 Europe Respiratory Drug Consumption and Value Analysis
7.1.1 Europe Respiratory Drug Market Under COVID-19
7.2 Europe Respiratory Drug Consumption Volume by Types
7.3 Europe Respiratory Drug Consumption Structure by Application
7.4 Europe Respiratory Drug Consumption by Top Countries
7.4.1 Germany Respiratory Drug Consumption Volume from 2016 to 2021
7.4.2 UK Respiratory Drug Consumption Volume from 2016 to 2021
7.4.3 France Respiratory Drug Consumption Volume from 2016 to 2021
7.4.4 Italy Respiratory Drug Consumption Volume from 2016 to 2021
7.4.5 Russia Respiratory Drug Consumption Volume from 2016 to 2021
7.4.6 Spain Respiratory Drug Consumption Volume from 2016 to 2021
7.4.7 Netherlands Respiratory Drug Consumption Volume from 2016 to 2021
7.4.8 Switzerland Respiratory Drug Consumption Volume from 2016 to 2021
7.4.9 Poland Respiratory Drug Consumption Volume from 2016 to 2021
Chapter 8 South Asia Respiratory Drug Market Analysis
8.1 South Asia Respiratory Drug Consumption and Value Analysis
8.1.1 South Asia Respiratory Drug Market Under COVID-19
8.2 South Asia Respiratory Drug Consumption Volume by Types
8.3 South Asia Respiratory Drug Consumption Structure by Application
8.4 South Asia Respiratory Drug Consumption by Top Countries
8.4.1 India Respiratory Drug Consumption Volume from 2016 to 2021
8.4.2 Pakistan Respiratory Drug Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Respiratory Drug Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Respiratory Drug Market Analysis
9.1 Southeast Asia Respiratory Drug Consumption and Value Analysis
9.1.1 Southeast Asia Respiratory Drug Market Under COVID-19
9.2 Southeast Asia Respiratory Drug Consumption Volume by Types
9.3 Southeast Asia Respiratory Drug Consumption Structure by Application
9.4 Southeast Asia Respiratory Drug Consumption by Top Countries
9.4.1 Indonesia Respiratory Drug Consumption Volume from 2016 to 2021
9.4.2 Thailand Respiratory Drug Consumption Volume from 2016 to 2021
9.4.3 Singapore Respiratory Drug Consumption Volume from 2016 to 2021
9.4.4 Malaysia Respiratory Drug Consumption Volume from 2016 to 2021
9.4.5 Philippines Respiratory Drug Consumption Volume from 2016 to 2021
9.4.6 Vietnam Respiratory Drug Consumption Volume from 2016 to 2021
9.4.7 Myanmar Respiratory Drug Consumption Volume from 2016 to 2021
Chapter 10 Middle East Respiratory Drug Market Analysis
10.1 Middle East Respiratory Drug Consumption and Value Analysis
10.1.1 Middle East Respiratory Drug Market Under COVID-19
10.2 Middle East Respiratory Drug Consumption Volume by Types
10.3 Middle East Respiratory Drug Consumption Structure by Application
10.4 Middle East Respiratory Drug Consumption by Top Countries
10.4.1 Turkey Respiratory Drug Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Respiratory Drug Consumption Volume from 2016 to 2021
10.4.3 Iran Respiratory Drug Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Respiratory Drug Consumption Volume from 2016 to 2021
10.4.5 Israel Respiratory Drug Consumption Volume from 2016 to 2021
10.4.6 Iraq Respiratory Drug Consumption Volume from 2016 to 2021
10.4.7 Qatar Respiratory Drug Consumption Volume from 2016 to 2021
10.4.8 Kuwait Respiratory Drug Consumption Volume from 2016 to 2021
10.4.9 Oman Respiratory Drug Consumption Volume from 2016 to 2021
Chapter 11 Africa Respiratory Drug Market Analysis
11.1 Africa Respiratory Drug Consumption and Value Analysis
11.1.1 Africa Respiratory Drug Market Under COVID-19
11.2 Africa Respiratory Drug Consumption Volume by Types
11.3 Africa Respiratory Drug Consumption Structure by Application
11.4 Africa Respiratory Drug Consumption by Top Countries
11.4.1 Nigeria Respiratory Drug Consumption Volume from 2016 to 2021
11.4.2 South Africa Respiratory Drug Consumption Volume from 2016 to 2021
11.4.3 Egypt Respiratory Drug Consumption Volume from 2016 to 2021
11.4.4 Algeria Respiratory Drug Consumption Volume from 2016 to 2021
11.4.5 Morocco Respiratory Drug Consumption Volume from 2016 to 2021
Chapter 12 Oceania Respiratory Drug Market Analysis
12.1 Oceania Respiratory Drug Consumption and Value Analysis
12.2 Oceania Respiratory Drug Consumption Volume by Types
12.3 Oceania Respiratory Drug Consumption Structure by Application
12.4 Oceania Respiratory Drug Consumption by Top Countries
12.4.1 Australia Respiratory Drug Consumption Volume from 2016 to 2021
12.4.2 New Zealand Respiratory Drug Consumption Volume from 2016 to 2021
Chapter 13 South America Respiratory Drug Market Analysis
13.1 South America Respiratory Drug Consumption and Value Analysis
13.1.1 South America Respiratory Drug Market Under COVID-19
13.2 South America Respiratory Drug Consumption Volume by Types
13.3 South America Respiratory Drug Consumption Structure by Application
13.4 South America Respiratory Drug Consumption Volume by Major Countries
13.4.1 Brazil Respiratory Drug Consumption Volume from 2016 to 2021
13.4.2 Argentina Respiratory Drug Consumption Volume from 2016 to 2021
13.4.3 Columbia Respiratory Drug Consumption Volume from 2016 to 2021
13.4.4 Chile Respiratory Drug Consumption Volume from 2016 to 2021
13.4.5 Venezuela Respiratory Drug Consumption Volume from 2016 to 2021
13.4.6 Peru Respiratory Drug Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Respiratory Drug Consumption Volume from 2016 to 2021
13.4.8 Ecuador Respiratory Drug Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Respiratory Drug Business
14.1 GSK
14.1.1 GSK Company Profile
14.1.2 GSK Respiratory Drug Product Specification
14.1.3 GSK Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 AstraZeneca
14.2.1 AstraZeneca Company Profile
14.2.2 AstraZeneca Respiratory Drug Product Specification
14.2.3 AstraZeneca Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Boehringer Ingelheim
14.3.1 Boehringer Ingelheim Company Profile
14.3.2 Boehringer Ingelheim Respiratory Drug Product Specification
14.3.3 Boehringer Ingelheim Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Vertex
14.4.1 Vertex Company Profile
14.4.2 Vertex Respiratory Drug Product Specification
14.4.3 Vertex Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Roche
14.5.1 Roche Company Profile
14.5.2 Roche Respiratory Drug Product Specification
14.5.3 Roche Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Novartis
14.6.1 Novartis Company Profile
14.6.2 Novartis Respiratory Drug Product Specification
14.6.3 Novartis Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Teva
14.7.1 Teva Company Profile
14.7.2 Teva Respiratory Drug Product Specification
14.7.3 Teva Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Chiesi
14.8.1 Chiesi Company Profile
14.8.2 Chiesi Respiratory Drug Product Specification
14.8.3 Chiesi Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Mylan
14.9.1 Mylan Company Profile
14.9.2 Mylan Respiratory Drug Product Specification
14.9.3 Mylan Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Sumitomo Dainippon
14.10.1 Sumitomo Dainippon Company Profile
14.10.2 Sumitomo Dainippon Respiratory Drug Product Specification
14.10.3 Sumitomo Dainippon Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Merck
14.11.1 Merck Company Profile
14.11.2 Merck Respiratory Drug Product Specification
14.11.3 Merck Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Beximco
14.12.1 Beximco Company Profile
14.12.2 Beximco Respiratory Drug Product Specification
14.12.3 Beximco Respiratory Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Respiratory Drug Market Forecast (2022-2027)
15.1 Global Respiratory Drug Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Respiratory Drug Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Respiratory Drug Value and Growth Rate Forecast (2022-2027)
15.2 Global Respiratory Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Respiratory Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Respiratory Drug Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Respiratory Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Respiratory Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Respiratory Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Respiratory Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Respiratory Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Respiratory Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Respiratory Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Respiratory Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Respiratory Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Respiratory Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Respiratory Drug Consumption Forecast by Type (2022-2027)
15.3.2 Global Respiratory Drug Revenue Forecast by Type (2022-2027)
15.3.3 Global Respiratory Drug Price Forecast by Type (2022-2027)
15.4 Global Respiratory Drug Consumption Volume Forecast by Application (2022-2027)
15.5 Respiratory Drug Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology

Add to Cart

Single User

$ 3300.00

Site License

$ 5250.00

Enterprisewide

$ 7000.00